MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$44,745K
Net Income
-$100,703K
Net Profit Margin
-225.06%
EPS
-$1.69
Unit: Thousand (K) dollars
Revenue Breakdown
US
Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
44,745
0
19,967
12,880
Cost of sales
2,996
1,319
1,879
1,679
Research and development
100,754
81,148
88,056
86,796
Selling, general and administrative
51,547
48,304
51,610
41,274
Total operating expenses
155,297
130,771
141,545
129,749
Loss from operations
-110,552
-110,025
-121,578
-116,869
Milestone payment from gain on sale of oncology business
-
0
0*
0
Gain on sale of contingent payments
-
0
0*
0
Interest income, net
9,730
10,795
12,410
13,369
Other income, net
119
119
113
67
Net (loss) income before taxes
-
0
-109,055*
-103,433
Income tax expense
-
0
-1,016*
0
Net loss
-100,703
-99,111
-108,039
-103,433
Basic EPS
-1.69
-1.69
-1.851
-1.78
Diluted EPS
-1.69
-1.69
-1.851
-1.78
Basic Average Shares
59,488,871
58,782,241
58,356,968
58,139,277
Diluted Average Shares
59,488,871
58,782,241
58,356,968
58,139,277
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$100,703K
(10.10%↑ Y/Y)
Interest income, net
$9,730K
(-32.96%↓ Y/Y)
Other income, net
$119K
(-77.25%↓ Y/Y)
US
$40,917K
Non Us
$3,828K
Loss from operations
-$110,552K
(12.99%↑ Y/Y)
Total revenue
$44,745K
(259.25%↑ Y/Y)
Total operating
expenses
$155,297K
(11.32%↑ Y/Y)
Research and development
$100,754K
(9.59%↑ Y/Y)
Selling, general and
administrative
$51,547K
(12.38%↑ Y/Y)
Cost of sales
$2,996K
(76.03%↑ Y/Y)
Buy us a coffee
AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. (AGIO)